COVID-19 vaccination showed effectiveness in reducing hospitalizations and severe disease outcomes associated with the SARS-CoV-2 JN.1 lineage, according to a recent study published in JAMA Network ...

Arbutus alleges that Moderna’s COVID-19 vaccine infringes on patents protecting its lipid nanoparticle delivery technology.

Booster vaccines reduced the risk of COVID‑19-related hospitalization and death, according to a new study of over 3 million adults who had the autumn 2022 vaccine in England. The research, led by the ...

Regulators move the goalposts for a manufacturer that uses mRNA technology.

Add Yahoo as a preferred source to see more of our stories on Google. Covid-19 infections continue to climb nationwide. And while updated vaccines are available, there is growing confusion over who is ...

FDA issues a Refusal to File letter to Moderna (NasdaqGS:MRNA) for its influenza vaccine candidate mRNA-1010. The decision centers on the choice of clinical trial comparator, not on safety or efficacy ...